We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.2B
AUM Growth
+$540M
(+0.81%)
Cap. Flow
-$425M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
780
New
63
Increased
245
Reduced
379
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$840M |
| 2 |
RTX Corp
RTX
|
+$638M |
| 3 |
Trane Technologies
TT
|
+$326M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$299M |
| 5 |
Gilead Sciences
GILD
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$489M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$397M |
| 3 |
ExxonMobil
XOM
|
+$325M |
| 4 |
Comcast
CMCSA
|
+$322M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$293M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.95% |
| 2 | Healthcare | 16.68% |
| 3 | Technology | 16.63% |
| 4 | Industrials | 11.79% |
| 5 | Consumer Discretionary | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LBY
301
DELISTED
Libbey, Inc.
LBY
| $20.2M | 0.03% |
506,150
-31,427
| -6% | -$1.11M |
|
302
Customers Bancorp
CUBI
$2.65B
| $19.5M | 0.03% |
799,580
+174,220
| +28% | +$3.76M |
|
|
FTD
303
DELISTED
FTD Companies, Inc. Common Stock
FTD
| $19.5M | 0.03% |
649,712
-1,477
| -0.2% | -$49.3K |
|
304
Brady Corp
BRC
$4.39B
| $19.4M | 0.03% |
686,607
-21,477
| -3% | -$584K |
|
305
Take-Two Interactive
TTWO
$44B
| $19.3M | 0.03% |
759,916
-43,397
| -5% | -$1.18M |
|
306
FreightCar America
RAIL
$235M
| $18.9M | 0.03% |
601,690
+176,810
| +42% | +$4.91M |
|
|
PRXL
307
DELISTED
Parexel International Corp
PRXL
| $18.8M | 0.03% |
272,208
-12,621
| -4% | -$804K |
|
|
AREX
308
DELISTED
Approach Resources Inc.
AREX
| $18.8M | 0.03% |
2,849,480
+160,570
| +6% | +$1.1M |
|
309
FerroAtlántica
GSM
$761M
| $18.6M | 0.03% |
984,382
-42,118
| -4% | -$710K |
|
310
Tetra Tech
TTEK
$9.36B
| $18.6M | 0.03% |
3,871,105
-590,790
| -13% | -$2.92M |
|
311
Live Nation Entertainment
LYV
$42.3B
| $18.6M | 0.03% |
736,915
-25,477
| -3% | -$643K |
|
312
Brink's
BCO
$4.57B
| $18.5M | 0.03% |
668,009
-34,739
| -5% | -$892K |
|
|
OB
313
DELISTED
Onebeacon Insurance Group Ltd
OB
| $18.4M | 0.03% |
1,211,164
-9,267
| -0.8% | -$145K |
|
|
KW
314
DELISTED
Kennedy-Wilson Holdings
KW
| $18M | 0.03% |
688,420
+135,501
| +25% | +$3.59M |
|
315
Cigna
CI
$73.7B
| $17.9M | 0.03% |
+138,617
| New | +$16.1M |
|
|
SEM
316
DELISTED
Select Medical
SEM
| $17.8M | 0.03% |
2,229,318
-112,195
| -5% | -$838K |
|
|
CKSW
317
DELISTED
CLICKSOFTWARE TECH LTD
CKSW
| $17.7M | 0.03% |
2,009,087
-89,510
| -4% | -$718K |
|
318
Granite Construction
GVA
$5.44B
| $17.6M | 0.03% |
500,416
-18,739
| -4% | -$651K |
|
319
First Citizens BancShares
FCNCA
$24.8B
| $17.2M | 0.03% |
66,047
-2,958
| -4% | -$731K |
|
320
Kemper
KMPR
$1.65B
| $17.1M | 0.03% |
437,780
+258,660
| +144% | +$9.55M |
|
|
YHOO
321
DELISTED
Yahoo Inc
YHOO
| $17M | 0.03% |
382,853
-1,797,349
| -82% | -$81.3M |
|
|
EXAR
322
DELISTED
Exar Corporation
EXAR
| $16.9M | 0.03% |
1,686,520
+248,560
| +17% | +$2.54M |
|
323
Qualcomm
QCOM
$175B
| $16.9M | 0.03% |
243,692
-3,756,751
| -94% | -$265M |
|
|
ACH
324
Accendra Health
ACH
$93.1M
| $16.7M | 0.02% |
494,667
-25,363
| -5% | -$884K |
|
325
CNO Financial Group
CNO
$5.12B
| $16.6M | 0.02% |
965,796
+100,820
| +12% | +$1.66M |
|
Similar funds
Boston Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Boston Partners held 780 positions worth $67.2B, up 0.81% from $66.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2015 filing shows 63 new, 245 increased, 379 reduced and 79 closed positions. Its largest new stake was Merck: 14,837,117 shares worth $814M. The largest sale was Citigroup, an estimated $489M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q1 2015 buy was Merck: 14,837,117 shares worth $814M.
- Boston Partners added most to RTX Corp in Q1 2015, an estimated $638M increase.
- Boston Partners's biggest Q1 2015 reduction was Citigroup, cutting an estimated $489M.
- Boston Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $397M.
- Boston Partners's ten largest holdings make up 17% of its $67.2B portfolio in Q1 2015.
- Boston Partners opened 63 new positions and closed 79 in Q1 2015.
- Boston Partners's portfolio value rose 0.81% quarter-over-quarter to $67.2B.
Based on Boston Partners's 13F filing for Q1 2015, filed 5 May 2015.